Table 3 Mean and difference among groups at baseline, posttreatment, and after 3 months of follow-up.
Outcomes | Unadjusted Mean (SD) | Between-group difference in score change | p | |
|---|---|---|---|---|
MA n = 33 | EA n = 33 | |||
Pain intensity (0–10) | ||||
Baseline | 7.9(1.7) | 7.8 (1.9) | ||
Posttreatment | 3.8 (2.7) | 4.2 (2.4) | −0.4 (−1.7 to 0.8) | 0.51 |
3 months | 3.7 (2.7) | 4.1 (2.6) | −0.4 (−1.7 to 0.9) | 0.54 |
Disability (0–24) | ||||
Baseline | 13.0 (5.1) | 16.3 (4.8) | ||
Posttreatment | 6.1 (5.0) | 8.7 (7.4) | −2.6 (−5.6 to 0.5) | 0.11 |
3 months | 8.4 (7.3) | 7.5 (7.1) | 0.9 (−2.6 to 4.5) | 0.59 |
McGill—Sensory (0–41) | ||||
Baseline | 17.3 (8.7) | 20.1 (7.6) | ||
Posttreatment | 8.0 (6.0) | 9.4 (7.3) | −1.4 (−4.7 to 1.9) | 0.40 |
3 months | 9.9 (8.9) | 10.5 (8.4) | −0.5 (−4.8 to 3.7) | 0.79 |
McGill—Affective (0–14) | ||||
Baseline | 4.3 (3.3) | 5.3 (3.3) | ||
Posttreatment | 1.7 (2.6) | 2.2 (3.1) | −0.5 (−1.9 to 0.9) | 0.47 |
3 months | 1.7 (2.4) | 1.8 (3.2) | −0.1 (−1.5 to −1.2) | 0.82 |
Quality of life | ||||
General health perceptions (0–100) | ||||
Baseline | 65.3 (77.4) | 60.1 (21.0) | ||
Posttreatment | 75.4 (16.4) | 65.6 (24.5) | 9.8 (−0.4 to 20.1) | 0.06 |
3 months | 70.4 (26.5) | 62.7 (26.0) | 7.6 (−5.2 to 20.5) | 0.24 |
Physical role functioning (0–100) | ||||
Baseline | 26.5 (36.9) | 25.7 (37.2) | ||
Posttreatment | 69.3 (41.0) | 49.4 (43.7) | 19.9 (−0.9 to 40.8) | 0.06 |
3 months | 52.2 (53.8) | 58.3 (52.5) | −6.0 (−32.2 to 20.1) | 0.64 |
Emotional role functioning (0–100) | ||||
Baseline | 59.5 (46.0) | 53.5 (46.3) | ||
Posttreatment | 77.5 (45.9) | 74.9 (41.3) | 2.6 (−18.9 to −24.1) | 0.81 |
3 months | 72.7 (48.9) | 82.8 (44.9) | −10 (−33.2 to −13.0) | 0.38 |
Mental health (0–100) | ||||
Baseline | 64.3 (23.3) | 62.3 (20.1) | ||
Posttreatment | 73.6 (18.2) | 70.5 (19.7) | 3.0 (−6.2 to 12.4) | 0.51 |
3 months | 69.4 (25.0) | 70.1 (26.7) | −0.7 (−13.4 to 12.0) | 0.91 |
Global perceived effect (−5 to 5) | ||||
Baseline | −2.1 (2.6) | −2.1 (2.8) | ||
Posttreatment | 3.4 (1.7) | 2.9 (1.4) | 0.5 (−0.2 to 1.3) | 0.17 |
3 months | 3.5 (1.6) | 3.2 (1.1) | 0.3 (−0.3 to 0.9) | 0.41 |
Kinesiophobia (17–68) | ||||
Baseline | 41.5 (4.8) | 44.9 (4.8) | ||
Posttreatment | 38.7 (4.9) | 42.8 (6.8) | −4.1 (−7.0 to −1.1) | 0.00* |
3 months | 38.6 (7.7) | 42.6 (6.7) | −4.0 (−7.5 to −0.4) | 0.00* |
Depression (0–63) | ||||
Baseline | 10.3 (7.7) | 13.4 (8.6) | ||
Posttreatment | 5.1 (6.6) | 7.3 (9.6) | −2.2 (−6.2 to 1.9) | 0.30 |
3 months | 7.9 (9.6) | 6.7 (10.6) | 1.2 (−3.8 to 6.1) | 0.64 |